Molecular modelling of human CYP2C subfamily enzymes CYP2C9 and CYP2C19: rationalization of substrate specificity and site-directed mutagenesis experiments in the CYP2C subfamily

By Lewis D. F. V.   Dickins M.   Weaver R. J.   Eddershaw P. J.   Goldfarb P. S.   Tarbit M. H.  

Xenobiotica, Vol. 28, Iss. 3, 1998-03 ,pp. : 235-268

Informa Healthcare

Access to resources Recommend Favorite

Substrate selectivity of human cytochrome P450 2C9: importance of residues 476, 365, and 114 in recognition of diclofenac and sulfaphenazole and in mechanism-based inactivation by tienilic acid

By Melet A.   Assrir N.   Jean P.   Pilar Lopez-Garcia M.   Marques-Soares C.   Jaouen M.   Dansette P.M.   Sari M-A.   Mansuy D.  

Archives of Biochemistry and Biophysics, Vol. 409, Iss. 1, 2003-01 ,pp. : 80-91

Elsevier

Access to resources Recommend Favorite

Cocktail-substrate assay system for mechanism-based inhibition of CYP2C9, CYP2D6, and CYP3A using human liver microsomes at an early stage of drug development

By Mori K.   Hashimoto H.   Takatsu H.   Tsuda-Tsukimoto M.   Kume T.  

Xenobiotica, Vol. 39, Iss. 6, 2009-06 ,pp. : 415-422

Informa Healthcare

Access to resources Recommend Favorite

Identification of CYP2C9 as a Human Liver Microsomal Linoleic Acid Epoxygenase

By Draper A.J.   Hammock B.D.  

Archives of Biochemistry and Biophysics, Vol. 376, Iss. 1, 2000-04 ,pp. : 199-205

Elsevier

Access to resources Recommend Favorite

CYP2C subfamily, primarily CYP2C9, catalyses the enantioselective demethylation of the endocrine disruptor pesticide methoxychlor in human liver microsomes: use of inhibitory monoclonal antibodies in P450 identification

By Hu Y.   Krausz K.   Gelboin H. V.   Kupfer D.  

Xenobiotica, Vol. 34, Iss. 2, 2004-02 ,pp. : 117-132

Informa Healthcare

Access to resources Recommend Favorite